220 publications
Package advice in practice - Deliberations for arriving at a fair package
The public debate pays a lot of attention to how we can continue to pay for health care in the future. A question that the ...
Semaglutide (Ozempic®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
Zorginstituut Nederland carried out a marginal assessment of whether semaglutide (Ozempic®) is interchangeable with a drug ...
Working method for the Zinnige Zorg (appropriate care) Programme
Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...
Hydrocortisone sodium phosphate (Softacor®) for the treatment of mild non-infectious allergic or inflammatory conjunctival diseases
Zorginstituut Nederland has carried out an assessment of the medicinal product hydrocortisone sodium phosphate (Softacor®) can be ...
Room for improvement analysis: Peripheral Arterial Disease – Zinnige Zorg
This Room for Improvement Analysis describes the research and the resulting actions and agreements that focus on further ...
Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD)
Zorginstituut Nederland has carried out an assessment of whether roflumilast (Daxas®) is interchangeable with a drug currently ...
SGLT2 inhibitors for the treatment of type 2 diabetes: relaxing List 2 conditions
Zorginstituut Nederland has carried out a substantive assessment of whether the existing list 2 conditions for SGLT2 inhibitors ...
Teduglutide (Revestive®) for the treatment of short bowel syndrome
The Minister of Health, Welfare and Sport (VWS) has asked Zorginstituut Nederland to carry out an assessment of teduglutide ...
Obeticholic acid (Ocaliva®) for the treatment of primary biliary cholangitis
Zorginstituut Nederland carried out an assessment of whether obeticholic acid (Ocaliva®) is interchangeable with a drug currently ...